Fresenius Medical Care Sodium Citrate 4% w/v Safe Lock - HSA Registration DE0503793
Access comprehensive regulatory information for Fresenius Medical Care Sodium Citrate 4% w/v Safe Lock in the Singapore medical device market through Pure Global AI's free database. This CLASS C medical device is registered under HSA registration number DE0503793 and owned by Fresenius Medical Care AG. The device was registered on November 05, 2019.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Sodium citrate 4% solution is intended for regional anticoagulation in continuous renal replacement therapies (CRRT) in adults: - Continuous veno-venous haemodialysis (Ci-Ca® CVVHD) - Post-dilution continuous veno-venous haemodiafiltration (Ci-Ca® post CVVHDF) Sodium citrate 4% solution must only be used with Fresenius Medical Care CRRT devices multiFiltrate and multiFiltratePRO for the mentioned blood processing therapies, and having integrated pumps to administer citrate and calcium.